巨子生物:妆品业务结构优化 医疗器械合规化加速

国联证券
11 Jan

事件2024 年11 月12 日,公司发布双11 战报,2024 年双11 期间可复美线上全渠道全周期GMV 同比增长80%,可丽金线上全渠道全周期GMV 同比增长150%+。2024 年12 月5 日,国家药品监督管理局医疗器械技术审评中心(CMDE)发布《医疗器械优先审批申请审核结果公示(2024 年第17 号)》,巨子生物申报的“注射用重组胶原蛋白填充剂”获医疗器械优先审批。2024 年12...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10